Scientific Opinion on the substantiation of health claims related to L-carnitine and faster recovery from muscle fatigue after exercise (ID 738, 1492, 1493), skeletal muscle tissue repair (ID 738, 1492, 1493), increase in endurance capacity (ID 4305, 4684

,

doi:10.2903/j.efsa.2011.2212

Cited by 17 publications

(5 citation statements)

References 8 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Following an application from Lonza Ltd., submitted for authorisation of a health claim pursuant to Article 13(5) of Regulation (EC) No 1924No /2006 via the Competent Authority of Germany, the European Food Safety Authority (EFSA) Panel on Dietetic Products, Nutrition and Allergies (NDA) was asked to deliver an opinion on the scientific substantiation of a health claim related to L-carnitine and contribution to normal lipid metabolism.…”

Section: Discussionmentioning

confidence: 99%

“…EFSA is requested to evaluate the scientific data submitted by the applicant in accordance with Article 16(3) of Regulation (EC) No 1924No /2006. On the basis of that evaluation, EFSA will issue an opinion on the scientific substantiation of a health claim related to: L-carnitine and contribution to normal lipid metabolism.…”

Section: Interpretation Of the Terms Of Referencementioning

confidence: 99%

“…It should be noted that such an assessment is not foreseen in the framework of Regulation (EC) No 1924No /2006 It should also be highlighted that the scope, the proposed wording of the claim and the conditions of use as proposed by the applicant may be subject to changes, pending the outcome of the authorisation procedure foreseen in Article 18 (4) …”

Section: Interpretation Of the Terms Of Referencementioning

confidence: 99%

“…The present opinion does not constitute, and cannot be construed as, an authorisation for the marketing of L-carnitine, a positive assessment of its safety, nor a decision on whether L-carnitine is, or is not, classified as a foodstuff. It should be noted that such an assessment is not foreseen in the framework of Regulation (EC) No 1924No /2006 It should also be highlighted that the scope, the proposed wording of the claim and the conditions of use as proposed by the applicant may be subject to changes, pending the outcome of the authorisation procedure foreseen in Article 18 (4)…”

Section: Interpretation Of the Terms Of Referencementioning

confidence: 99%

“…L-carnitine is the form commonly used in food supplements. The content of L-carnitine in foods can be measured by established methods (EFSA NDA Panel, 2011b).…”

Section: Characterisation Of the Food/constituentmentioning

confidence: 99%

See 4 more Smart Citations

L‐carnitine and contribution to normal lipid metabolism: evaluation of a health claim pursuant to Article 13(5) of Regulation (EC) No 1924/2006

Turck¹,

Bresson²,

Burlingame³

et al. 2018

EFS2

View full text Add to dashboard Cite

Following an application from Lonza Ltd., submitted for authorisation of a health claim pursuant to Article 13(5) of Regulation (EC) No 1924/2006 via the Competent Authority of Germany, the EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA) was asked to deliver an opinion on the scientific substantiation of a health claim related to L‐carnitine and normal lipid metabolism. The food that is proposed as the subject of the health claim is L‐carnitine. The Panel considers that L‐carnitine is sufficiently characterised. The claimed effect proposed by the applicant is ‘normal lipid metabolism’. The target population proposed by the applicant is the general population. The Panel considers that contribution to normal lipid metabolism is a beneficial physiological effect. The applicant proposes that the claim submitted with this application is based on the essentiality of a nutrient. The Panel considers that the evidence provided does not establish that dietary L‐carnitine is required to maintain normal lipid metabolism in the target population, for which the claim is intended. The Panel concludes that a cause and effect relationship has not been established between the consumption of L‐carnitine and contribution to normal lipid metabolism in the target population.

show abstract

Section: Discussionmentioning

confidence: 99%

Section: Interpretation Of the Terms Of Referencementioning

confidence: 99%

Section: Interpretation Of the Terms Of Referencementioning

confidence: 99%

Section: Interpretation Of the Terms Of Referencementioning

confidence: 99%

“…L-carnitine is the form commonly used in food supplements. The content of L-carnitine in foods can be measured by established methods (EFSA NDA Panel, 2011b).…”

Section: Characterisation Of the Food/constituentmentioning

confidence: 99%

See 3 more Smart Citations